CN Patent

CN101208339B — 杂环苄基氨基衍生物，它们的制备以及作为药剂的应用

Assigned to F Hoffmann La Roche AG · Expires 2010-12-29 · 15y expired

What this patent protects

本发明的目的是式(I)的化合物，它们的药用盐，对映体形式，非对映异构体和外消旋物，上述化合物的制备，含有它们的药物组合物和它们的制备，以及上述化合物在控制或预防诸如癌症的疾病中的应用。

USPTO Abstract

本发明的目的是式(I)的化合物，它们的药用盐，对映体形式，非对映异构体和外消旋物，上述化合物的制备，含有它们的药物组合物和它们的制备，以及上述化合物在控制或预防诸如癌症的疾病中的应用。

Drugs covered by this patent

taletrectinib-adipate (TALETRECTINIB ADIPATE)

Patent Metadata

Patent number: CN101208339B
Jurisdiction: CN
Classification: —
Expires: 2010-12-29
Drug substance claim: No
Drug product claim: No
Assignee: F Hoffmann La Roche AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.